S&P 500   4,198.00 (-0.18%)
DOW   32,936.40 (-0.47%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.52 (+1.17%)
TSLA   199.95 (+3.51%)
NVDA   403.60 (+3.63%)
NIO   7.39 (-4.03%)
BABA   78.34 (-3.25%)
AMD   126.10 (-0.73%)
T   15.67 (+1.10%)
F   12.62 (+4.38%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.27 (-0.46%)
DIS   87.46 (-0.94%)
AMC   4.59 (-1.08%)
PFE   37.02 (-1.54%)
PYPL   61.19 (+1.61%)
NFLX   392.66 (+3.64%)
S&P 500   4,198.00 (-0.18%)
DOW   32,936.40 (-0.47%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.52 (+1.17%)
TSLA   199.95 (+3.51%)
NVDA   403.60 (+3.63%)
NIO   7.39 (-4.03%)
BABA   78.34 (-3.25%)
AMD   126.10 (-0.73%)
T   15.67 (+1.10%)
F   12.62 (+4.38%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.27 (-0.46%)
DIS   87.46 (-0.94%)
AMC   4.59 (-1.08%)
PFE   37.02 (-1.54%)
PYPL   61.19 (+1.61%)
NFLX   392.66 (+3.64%)
S&P 500   4,198.00 (-0.18%)
DOW   32,936.40 (-0.47%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.52 (+1.17%)
TSLA   199.95 (+3.51%)
NVDA   403.60 (+3.63%)
NIO   7.39 (-4.03%)
BABA   78.34 (-3.25%)
AMD   126.10 (-0.73%)
T   15.67 (+1.10%)
F   12.62 (+4.38%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.27 (-0.46%)
DIS   87.46 (-0.94%)
AMC   4.59 (-1.08%)
PFE   37.02 (-1.54%)
PYPL   61.19 (+1.61%)
NFLX   392.66 (+3.64%)
S&P 500   4,198.00 (-0.18%)
DOW   32,936.40 (-0.47%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.52 (+1.17%)
TSLA   199.95 (+3.51%)
NVDA   403.60 (+3.63%)
NIO   7.39 (-4.03%)
BABA   78.34 (-3.25%)
AMD   126.10 (-0.73%)
T   15.67 (+1.10%)
F   12.62 (+4.38%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.27 (-0.46%)
DIS   87.46 (-0.94%)
AMC   4.59 (-1.08%)
PFE   37.02 (-1.54%)
PYPL   61.19 (+1.61%)
NFLX   392.66 (+3.64%)
Top-Rated StocksTop-Rated
NYSE:IQV

IQVIA (IQV) Stock Forecast, Price & News

$199.18
-0.27 (-0.14%)
(As of 01:20 PM ET)
Compare
Today's Range
$198.38
▼
$202.50
50-Day Range
$183.66
▼
$202.99
52-Week Range
$165.75
▼
$249.11
Volume
384,911 shs
Average Volume
1.06 million shs
Market Capitalization
$36.96 billion
P/E Ratio
35.82
Dividend Yield
N/A
Price Target
$253.25
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

IQVIA MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.92 Rating Score
Upside/​Downside
26.3% Upside
$253.25 Price Target
Short Interest
Healthy
1.09% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.73mentions of IQVIA in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.58%
From $9.28 to $10.54 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Business Services Sector

41st out of 346 stocks

Commercial Physical Research Industry

4th out of 16 stocks

See Top Rated MarketRank™ Stocks Here

IQV stock logo

About IQVIA (NYSE:IQV) Stock

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Receive IQV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IQVIA and its competitors with MarketBeat's FREE daily newsletter.

IQV Stock News Headlines

May 30, 2023 | americanbankingnews.com
IQVIA Holdings Inc. (NYSE:IQV) Short Interest Up 24.2% in May
May 27, 2023 | americanbankingnews.com
Q3 2023 EPS Estimates for IQVIA Holdings Inc. Raised by Zacks Research (NYSE:IQV)
May 30, 2023 | Edge On The Street (Ad)
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
May 26, 2023 | msn.com
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
May 26, 2023 | americanbankingnews.com
IQVIA (NYSE:IQV) Shares Gap Down to $201.78
May 25, 2023 | finance.yahoo.com
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
May 25, 2023 | msn.com
Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
May 24, 2023 | finance.yahoo.com
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
May 30, 2023 | Edge On The Street (Ad)
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
May 23, 2023 | finance.yahoo.com
IQVIA's (IQV) Extensive Database Blocks New Entrants
May 23, 2023 | msn.com
IQVIA Holdings: A Possible Beat And Raise Scenario In The Works
May 22, 2023 | bizjournals.com
Iqvia raises $1.25 billion in upsized offering
May 18, 2023 | nytimes.com
Drug Shortages Near an All-Time High, Leading to Rationing
May 18, 2023 | nj.com
Can’t get your medicine? An inside look at the massive drug shortages in N.J. and beyond.
May 18, 2023 | finance.yahoo.com
Medical Device Contract Research Organization Global Market Report 2023: Featuring IQVIA, Charles River Laboratories, ICON, Syneos Health & More
May 18, 2023 | markets.businessinsider.com
IQVIA To Raise $1 Bln Through Notes Offering
May 18, 2023 | finance.yahoo.com
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
May 18, 2023 | americanbankingnews.com
IQVIA (NYSE:IQV) Now Covered by Analysts at StockNews.com
May 15, 2023 | americanbankingnews.com
IQVIA Holdings Inc. (NYSE:IQV) Receives $253.07 Average PT from Brokerages
May 13, 2023 | msn.com
Cancer therapies spending set to surge through end of decade
May 11, 2023 | finance.yahoo.com
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
May 11, 2023 | marketwatch.com
IQVIA Holdings Inc. stock rises Wednesday, outperforms market
May 10, 2023 | marketwatch.com
IQVIA Holdings Inc. stock rises Monday, outperforms market
May 10, 2023 | marketwatch.com
IQVIA Holdings Inc. stock falls Tuesday, underperforms market
May 2, 2023 | finance.yahoo.com
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
May 2, 2023 | americanbankingnews.com
IQVIA (NYSE:IQV) PT Lowered to $220.00
May 2, 2023 | americanbankingnews.com
IQVIA (NYSE:IQV) PT Lowered to $244.00 at Truist Financial
See More Headlines
Receive IQV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IQVIA and its competitors with MarketBeat's FREE daily newsletter.

IQV Company Calendar

Last Earnings
2/10/2023
Today
5/30/2023
Next Earnings (Estimated)
7/20/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Commercial physical research
Sub-Industry
N/A
Sector
Business Services
Current Symbol
NYSE:IQV
CUSIP
N/A
CIK
1478242
Web
www.iqvia.com
Phone
(919) 998-2000
Fax
N/A
Employees
86,000
Year Founded
2016

Price Target and Rating

Average Stock Price Forecast
$253.25
High Stock Price Forecast
$275.00
Low Stock Price Forecast
$220.00
Forecasted Upside/Downside
+26.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
12 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$5.56
Trailing P/E Ratio
35.89
Forward P/E Ratio
21.51
P/E Growth
2
Net Income
$1.09 billion
Net Margins
7.28%
Pretax Margin
9.14%
Return on Equity
30.95%
Return on Assets
6.95%

Debt

Debt-to-Equity Ratio
1.99
Current Ratio
0.80
Quick Ratio
0.80

Sales & Book Value

Annual Sales
$14.41 billion
Price / Sales
2.57
Cash Flow
$15.78 per share
Price / Cash Flow
12.65
Book Value
$31.04 per share
Price / Book
6.43

Miscellaneous

Outstanding Shares
185,550,000
Free Float
182,766,000
Market Cap
$37.03 billion
Optionable
Optionable
Beta
1.39

Social Links


Key Executives

  • Ari BousbibAri Bousbib
    Chairman, President & Chief Executive Officer
  • James Grant Berkshire
    Senior Vice President-Business Operations
  • Ronald Earl BruehlmanRonald Earl Bruehlman
    Chief Financial Officer & Executive Vice President
  • Costa Panagos
    President-Research & Development Solutions
  • Karl Guenault
    Chief Information Officer & Senior Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













IQV Stock - Frequently Asked Questions

Should I buy or sell IQVIA stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IQVIA in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IQV shares.
View IQV analyst ratings or view top-rated stocks.

What is IQVIA's stock price forecast for 2023?

12 analysts have issued 1 year target prices for IQVIA's stock. Their IQV share price forecasts range from $220.00 to $275.00. On average, they anticipate the company's stock price to reach $253.25 in the next twelve months. This suggests a possible upside of 26.9% from the stock's current price.
View analysts price targets for IQV or view top-rated stocks among Wall Street analysts.

How have IQV shares performed in 2023?

IQVIA's stock was trading at $204.89 at the start of the year. Since then, IQV shares have decreased by 2.6% and is now trading at $199.57.
View the best growth stocks for 2023 here.

Are investors shorting IQVIA?

IQVIA saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,000,000 shares, an increase of 24.2% from the April 30th total of 1,610,000 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is currently 1.7 days. Approximately 1.1% of the company's stock are sold short.
View IQVIA's Short Interest.

When is IQVIA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 20th 2023.
View our IQV earnings forecast.

How were IQVIA's earnings last quarter?

IQVIA Holdings Inc. (NYSE:IQV) announced its quarterly earnings results on Friday, February, 10th. The medical research company reported $2.78 earnings per share for the quarter, beating the consensus estimate of $2.76 by $0.02. The medical research company earned $3.74 billion during the quarter, compared to the consensus estimate of $3.71 billion. IQVIA had a net margin of 7.28% and a trailing twelve-month return on equity of 30.95%. The business's revenue was up 2.8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.42 earnings per share.
Read the conference call transcript.

What ETFs hold IQVIA's stock?

ETFs with the largest weight of IQVIA (NYSE:IQV) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), VanEck Biotech ETF (BBH), iShares Biotechnology ETF (IBB), First Trust NYSE Arca Biotechnology Index Fund (FBT), Simplify Health Care ETF (PINK), American Century Mid Cap Growth Impact (MID), Natixis Vaughan Nelson Mid Cap ETF (VNMC) and Invesco S&P 500 Equal Weight Health Care ETF (RYH).

What guidance has IQVIA issued on next quarter's earnings?

IQVIA issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $10.26-$10.56 for the period, compared to the consensus estimate of $10.43. The company issued revenue guidance of $15.15 billion-$15.40 billion, compared to the consensus revenue estimate of $15.27 billion.

What is Ari Bousbib's approval rating as IQVIA's CEO?

1,545 employees have rated IQVIA Chief Executive Officer Ari Bousbib on Glassdoor.com. Ari Bousbib has an approval rating of 84% among the company's employees.

What other stocks do shareholders of IQVIA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IQVIA investors own include CA (CA), BlackRock (BLK), NVIDIA (NVDA), Micron Technology (MU), Endologix (ELGX), Chipotle Mexican Grill (CMG), Alibaba Group (BABA), PayPal (PYPL), Salesforce (CRM) and Accenture (ACN).

What is IQVIA's stock symbol?

IQVIA trades on the New York Stock Exchange (NYSE) under the ticker symbol "IQV."

Who are IQVIA's major shareholders?

IQVIA's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.45%), State Street Corp (4.44%), FMR LLC (3.03%), Geode Capital Management LLC (2.05%), Farallon Capital Management LLC (1.73%) and Longview Partners Guernsey LTD (1.46%). Insiders that own company stock include Ari Bousbib, Eric Sherbet, Group Holdings (Sbs) Advis Tpg, John Connaughton, John G Danhakl, Kevin C Knightly, Ronald A Rittenmeyer and Ronald E Bruehlman.
View institutional ownership trends.

How do I buy shares of IQVIA?

Shares of IQV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IQVIA's stock price today?

One share of IQV stock can currently be purchased for approximately $199.57.

How much money does IQVIA make?

IQVIA (NYSE:IQV) has a market capitalization of $37.03 billion and generates $14.41 billion in revenue each year. The medical research company earns $1.09 billion in net income (profit) each year or $5.56 on an earnings per share basis.

How many employees does IQVIA have?

The company employs 86,000 workers across the globe.

Does IQVIA have any subsidiaries?
The following companies are subsidiares of IQVIA: 159 Solutions LLC, 159 Technology Solutions Private Ltd, AECIO IT Solutions India Private Ltd., ALIMED Egeszsegugyi Szolgaltato Kft., Advanced Health Media LLC, Advanced Health Media Services Ltd., Aileron Solutions, Albatross Financial Solutions Limited, Allcare Plus Pharmacy LLC, Aposphäre GmbH, Appature Inc., Ardentia International Limited, Ascott Sales Integration Pty Ltd, Asesorias IQVIA Solutions Chile Limitada, Asserta Centroamerica Medicion de Mercados S.A., Avacare Clinical Research Network (Shanghai) Co. Ltd., BUZZEOPDMA LLC, Battaerd Mansley (Proprietary) Limited, Battaerd Mansley Pty. Ltd., Benefit Holding Inc., Biofortis LLC, Branch of IQVIA RDS GesmbH in Novosibirsk, Branch of IQVIA RDS GesmbH in St. Petersburg, CDS - Centre de Service SAS, CFS Clinical UK Limited, CRM Health Korea Ltd., CSD Health Korea Ltd., CT Clinical Portugal Unipessoal Lda, CT Clinical Services Eood, CT Consulting Inc., Cambridge Pharma Consultancy Inc., Cambridge Pharma Consultancy Limited, Cegedim Venezuela C.A., Cenduit (India) Services Private Company Limited, Cenduit GmbH, Cenduit Holdings LLC, Cenduit LLC, Cenduit LLC Shanghai Rep. Office, Cenduit Limited, Cenduit Mauritius Holdings Company, Centrix Innovations (Pty) Ltd., ClinTec Austria GmbH, ClinTec CRO Services (India) Private Limited, ClinTec Gesellschaft fur Klinische Entwicklung GmbH, ClinTec International (Pty) Ltd., ClinTec International (Pty) Ltd. (Malawi branch), ClinTec International (Thailand) Limited, ClinTec International AG, ClinTec International Belgium BV, ClinTec International Bulgaria OOD, ClinTec International Co. Ltd., ClinTec International Denmark ApS, ClinTec International FZ-LLC, ClinTec International Hong Kong Limited, ClinTec International Hungary Kft, ClinTec International Italy S.r.l., ClinTec International LLC, ClinTec International Limited, ClinTec International Ltd (Netherlands Branch), ClinTec International Ltd UK Filial Sverige, ClinTec International Ltd., ClinTec International Norway AS, ClinTec International Off-Shore S.A.L., ClinTec International Pte Ltd., ClinTec International Pty Ltd, ClinTec International RUS LLC, ClinTec International Romania S.R.L., ClinTec International S.à r.l., ClinTec International SL, ClinTec International Services Inc., ClinTec International d.o.o. za trgov inuisludge, ClinTec International doo, ClinTec International s.r.o., ClinTec International sp. z.o.o., ClinTec Luxembourg S.A., ClinTec Turkey Medikal ve Farmasotik Hizmetler Ticaret Limited Sirketi, ClinTech Ireland International Research Limited, Clinical Financial Services LLC, Clinical Insourcing Solutions Limited, Clinical Insourcing Solutions S. de R.L. de C.V., Clinical Lab Minority Shareholder Limited, Clintec International Inc., Clintec International Pharmaceutical Services Ltd, Compliant Community Projects (Pty) Ltd., CoreZetta Co Ltd., Data Niche Associates Inc., Dataline Software Limited, Datandina Ecuador S.A., Datec Industria e Comercio Distribudora Grafica e Mala Direta Ltda., Dimensions Healthcare Company Ltd, Dimensions Healthcare LLC, Dimensions Healthcare LLC (Dubai Branch), DrugDev, DrugDev Inc., DrugDev Limited, EA Institute L.L.C., EPID Research Oy, EPID Research Sweden, EPS Research Limited, EPS Software Limited, Enterprise Associates L.L.C., Epernicus LLC, Excel Life Sciences Inc., Excel Life Sciences Pvt Ltd India, Forcea NV, Foresight IT Solutions and Consulting India Private Limited, GCE Clin Solutions Limited, GCE Global Solutions LLC, GCE Solutions GmbH, GCE Solutions International LLC, GCE Solutions Proprietary Limited, GCE Solutions S. de R.L. de C.V., Global Crown Investment Limited, Grace Data Corp., HighPoint Solutions LLC, Highpoint Solutions LLC (Geneva Branch), Hospital Marketing Services Ltd., Hotel Lot C-8B LLC, IMS (UK) Pension Plan Trustee Company Limited, IMS AB, IMS Government Solutions Inc., IMS HEALTH GROUP LIMITED, IMS HEALTH KOREA LTD., IMS Health (Australia) Partnership, IMS Health Analytics Services Private Limited, IMS Health Information Solutions Australia Pty. Ltd, IMS Health Information Solutions India Private Ltd., IMS Health Networks Limited, IMS Health Paraguay SRL, IMS Health Surveys Limited, IMS Health Uruguay S.A., IMS Health de Venezuela C.A., IMS Hospital Group Limited, IMS Information Solutions Medical Research Limited, IMS Information Solutions UK Ltd., IMS International (Proprietary) Limited, IMS Meridian Limited, IMS Meridian Research Limited, IMS SOFTWARE SERVICES LTD., IMS Technology Solutions UK Limited, INCARNUS MALAYSIA SDN BHD, IPP Informacion Promocional y Publicitaria S.A. de C.V., IQVIA (Thailand) Co. Ltd., IQVIA AB, IQVIA AG, IQVIA AG (Basal Branch), IQVIA AG (Dubai Branch), IQVIA AG (Mexico Branch), IQVIA AG (Representative Office - Algeria), IQVIA AG (Representative Office - Dubai), IQVIA AG (Representative Office - Jordan), IQVIA AG (Representative Office - Lebanon), IQVIA AG (Representative Office - Serbia), IQVIA AG (Rotkreuz Branch), IQVIA AG (UK Branch), IQVIA Adriatic d.o.o. za Konzalting, IQVIA Asia Pacific Commercial Holdings LLC, IQVIA Beteiligungsgesellschaft mbH, IQVIA BioSciences Holdings LLC, IQVIA Biotech LLC, IQVIA Biotech Ltd., IQVIA CHINAMETRIK INC., IQVIA COMMERCIAL FINANCE INC., IQVIA COMMERCIAL INDIA HOLDINGS CORP., IQVIA COMMERCIAL SERVICES LLC, IQVIA COMMERCIAL TRADING CORP., IQVIA CSMS GmbH, IQVIA CSMS US Inc., IQVIA Clinical AB, IQVIA Clinical Filial af IQVIA Clinical AB, IQVIA Commercial Consulting Sp. z.o.o., IQVIA Commercial Deutschland GmbH, IQVIA Commercial GmbH & Co. OHG, IQVIA Commercial I LLC, IQVIA Commercial Software GmbH, IQVIA Commercial Sp. z.o.o., IQVIA Consulting Solutions BV, IQVIA Consulting and Information Services India Private Limited, IQVIA FZ-LLC, IQVIA Finance Ireland Designated Activity Company, IQVIA GOVERNMENT SOLUTIONS INC., IQVIA Healthcare (QFC Branch), IQVIA Hellas Technology Solutions Single Member S.A., IQVIA Holdings (UK) Ltd., IQVIA Holdings France SAS, IQVIA IES Brasil Ltda., IQVIA IES Denmark ApS, IQVIA IES Europe Limited, IQVIA IES European Holdings, IQVIA IES Italia S.r.l., IQVIA IES OY, IQVIA IES Overseas Holdings Limited, IQVIA IES Portugal Unipessoal LDA, IQVIA IES Puerto Rico Inc., IQVIA IES South Africa (Pty) Limited, IQVIA IES UK Limited, IQVIA II Technology Solutions Portugal Unipessoal LDA, IQVIA INC., IQVIA INFORMATION MEDICAL STATISTICS (ISRAEL) LTD., IQVIA Inc. (Thailand Branch), IQVIA Information S.A., IQVIA Information Solutions (China) Co. Ltd., IQVIA Information Solutions GmbH, IQVIA Integrated Services NL, IQVIA Investment Holdings Limited, IQVIA Korea Co. Ltd., IQVIA LTD., IQVIA Lebanon S.a.r.l., IQVIA Market Intelligence LLC, IQVIA Marktforschung GmbH, IQVIA Maroc S.à r.l., IQVIA MedTech Inc., IQVIA MedTech NV, IQVIA Medical Communications & Consulting Inc., IQVIA Medical Development (Dalian) Co. Ltd., IQVIA Medical Education Inc., IQVIA Medical Radar AB, IQVIA Operations France SAS, IQVIA PHARMA Inc., IQVIA Partners AS, IQVIA Pharma Services Corp., IQVIA Pharmaceutical Marketing Services Ltd., IQVIA Phase One Services LLC, IQVIA RDS (India) Private Ltd., IQVIA RDS (Pty.) Limited, IQVIA RDS (Shanghai) Co. Ltd., IQVIA RDS AG, IQVIA RDS Argentina S.R.L., IQVIA RDS Asia Inc., IQVIA RDS Austria GmbH, IQVIA RDS BT Inc., IQVIA RDS Brasil Ltda., IQVIA RDS Bulgaria EOOD, IQVIA RDS Canada ULC, IQVIA RDS Chile, IQVIA RDS Clindata (Pty.) Ltd., IQVIA RDS Clindepharm (Pty.) Ltd., IQVIA RDS Colombia S.A.S., IQVIA RDS Costa Rica S.A., IQVIA RDS Czech Republic s.r.o., IQVIA RDS ESTONIA OU, IQVIA RDS East Asia Pte. Ltd., IQVIA RDS Eastern Holdings GmbH, IQVIA RDS Egypt LLC, IQVIA RDS Finland OY, IQVIA RDS France SAS, IQVIA RDS Funding LLC, IQVIA RDS GesmbH, IQVIA RDS GmbH, IQVIA RDS Guatemala S.A., IQVIA RDS Hellas Single Member S.A., IQVIA RDS Holdings, IQVIA RDS Hong Kong Limited, IQVIA RDS Hungary Pharmaceutical Development and Consulting Limited Liability Company, IQVIA RDS ISRAEL LTD., IQVIA RDS Inc., IQVIA RDS Ireland (Finance) Ltd., IQVIA RDS Ireland Ltd., IQVIA RDS Italy S.r.l., IQVIA RDS Latin America LLC, IQVIA RDS Latin America LLC (Argentina Branch), IQVIA RDS Latvia SIA, IQVIA RDS Malaysia Sdn. Bhd., IQVIA RDS Netherlands B.V., IQVIA RDS Norway, IQVIA RDS Panama Inc., IQVIA RDS Peru S.r.l., IQVIA RDS Philippines Inc., IQVIA RDS Poland Sp. Zoo, IQVIA RDS Pty. Limited, IQVIA RDS Pty. Ltd., IQVIA RDS Slovakia s.r.o., IQVIA RDS South Africa (Pty.) Ltd., IQVIA RDS Spain S.L., IQVIA RDS Spain S.L. - Representação Permanente em Portugal, IQVIA RDS Switzerland S.à r.l., IQVIA RDS Taiwan Ltd., IQVIA RDS UAB, IQVIA RDS UK Holdings Ltd., IQVIA RDS Ukraine, IQVIA RDS Vietnam LLC, IQVIA RDS and Integrated Services Belgium NV, IQVIA RDS d.o.o. Beograd, IQVIA Research and Development Solutions Saudi Arabia Limited, IQVIA Romania S.R.L., IQVIA SOLUTIONS CANADA INC, IQVIA SOLUTIONS JAPAN K.K., IQVIA Services Japan K.K., IQVIA Solutions (NZ) Limited, IQVIA Solutions (Pty.) Ltd., IQVIA Solutions Argentina S.A., IQVIA Solutions Asia Pte. Ltd, IQVIA Solutions Australia Holdings Pty. Ltd., IQVIA Solutions Australia Pty. Ltd., IQVIA Solutions B.V., IQVIA Solutions Bangladesh Limited, IQVIA Solutions Belgium BV, IQVIA Solutions Bolivia S.R.L., IQVIA Solutions Bulgaria EOOD, IQVIA Solutions Colombia S.A., IQVIA Solutions Consulting Myanmar Company Limited, IQVIA Solutions Denmark AS, IQVIA Solutions Egypt Ltd., IQVIA Solutions Enterprise Management Consulting (Shanghai) Co. Ltd (Beijing Branch), IQVIA Solutions Enterprise Management Consulting (Shanghai) Co. Ltd., IQVIA Solutions Finance B.V., IQVIA Solutions Finance UK I Ltd., IQVIA Solutions Finance UK II Ltd., IQVIA Solutions Finance UK III Ltd., IQVIA Solutions Finance UK V Ltd., IQVIA Solutions Finland OY, IQVIA Solutions Global Holdings UK Ltd., IQVIA Solutions HQ Ltd., IQVIA Solutions Holdings (Pty.) Ltd., IQVIA Solutions Hong Kong Limited, IQVIA Solutions Ireland Limited, IQVIA Solutions Italy S.r.l., IQVIA Solutions Kazakhstan LLC, IQVIA Solutions LLC, IQVIA Solutions Lanka (Private) Limited, IQVIA Solutions Malaysia Sdn. Bhd., IQVIA Solutions Norway AS, IQVIA Solutions Operations Center Philippines Inc., IQVIA Solutions Pakistan (Private) Limited, IQVIA Solutions Pharmaceutical SRL, IQVIA Solutions Philippines Inc., IQVIA Solutions Portugal Lda, IQVIA Solutions Puerto Rico Inc., IQVIA Solutions Regional Pte. Ltd., IQVIA Solutions Republica Dominicana S.R.L., IQVIA Solutions Saudi Arabia Limited, IQVIA Solutions Services Ltd., IQVIA Solutions Sweden AB, IQVIA Solutions Tunisia S.à r.l., IQVIA Solutions UK Investments Ltd., IQVIA Solutions UK Limited, IQVIA Solutions a.s., IQVIA Solutions del Peru S.A., IQVIA Solutions do Brasil Ltda., IQVIA Solutions s.r.o., IQVIA Soluções de Tecnologia do Brasil Ltda, IQVIA Staff Services Sp.A., IQVIA TRANSPORTATION SERVICES CORP., IQVIA Technology Services Ltd., IQVIA Technology Solutions (China) Co. Ltd., IQVIA Technology Solutions Colombia Ltda., IQVIA Technology Solutions Egypt LLC, IQVIA Technology Solutions Finland OY, IQVIA Technology Solutions Poland SP. z.o.o, IQVIA Technology Solutions Romania Srl, IQVIA Technology Solutions S.R.O. (Bulgaria Branch), IQVIA Technology Solutions Ukraine LLC, IQVIA Technology Solutions s.r.o., IQVIA Technology Tunisia S.à r.l., IQVIA Tibbi Istatistik Ticaret ve Musavirlik Ltd. Sirketi, IQVIA Trading Management Inc., IQVIA World Publications Ltd., IQVIA Zagreb d.o.o., Iasist Holdco Limited, Iasist Portugal Consultadoria na Área de Saúde Unipessoal Lda, Iasist SAU Agencia en Chile, Iasist Sociedad Anonima Unipersonal, Impact RX Data Management (Pty) Ltd., Infocus Health Limited, Infopharm Ltd., Innovex Holdings I LLC, Innovex Merger Corp., Innovex Saglik Urunleri Pazarlame ve Hizmet Danismanlik Anonim Sirketi, Intercontinental Medical Statistics International Ltd., Intercontinental Medical Statistics Kenya Ltd., Interface Clinical Services Ltd., Interstatistik AG, Iqvia Solutions Taiwan Ltd., Jäger Health Gmbh, Kun Tai Medical Development Hong Kong Limited, Kun Tuo Medical Research & Development (Beijing) Co. Ltd., Laboratorio Commuq Pharma SLU, Linguamatics, Linguamatics Limited, Linguamatics Solutions Limited, M&H Informatics (BD) LTD., Mecurial Insights Holding Pty. Ltd., Mecurial Insights Pty. Ltd., Med-Vantage Inc., Meddata Group LLC, MedicSense Ltd., Medineos S.r.l., Mercados Y Analisis S.A., Meridian Research Vietnam Ltd., Novasyte LLC, Novella Clinical LLC, Novex Pharma Laboratorio S.L., Novex Pharma Limited, Nuevo Health Pty Ltd, Operaciones Centralizadas Latinoamericana Limitada, Optimum Contact Limited, Outcome Sciences LLC, PR Editions S.A.S., PT IQVIA RDS Indonesia, PT IQVIA Solutions Indonesia, Penderwood Limited, PharmARC Consulting Services GmbH, PharmARC Inc., Pharma Deals Limited, Pharma Strategy Group Limited, Pharmadata s.r.o., Pharmaforce S.A. de C.V., Polaris Management Partners LLC, Polaris Solutions LLC, Polaris Solutions Ltd., Privacy Analytics Inc., Professional Pharmaceutical Marketing Services (Pty.) Ltd., Prometheus Research LLC, Public Relations Algeria, Q Squared Solutions (Beijing) Co. Ltd., Q Squared Solutions (India) Private Limited, Q Squared Solutions (Quest) LLC, Q Squared Solutions (Quest) Limited, Q Squared Solutions (Shanghai) Co. Ltd., Q Squared Solutions B.V., Q Squared Solutions BioSciences LLC, Q Squared Solutions China (Quest) Limited, Q Squared Solutions China Limited, Q Squared Solutions Expression Analysis LLC, Q Squared Solutions Holdings B.V., Q Squared Solutions Holdings LLC, Q Squared Solutions Holdings Limited, Q Squared Solutions KK, Q Squared Solutions LLC, Q Squared Solutions Limited, Q Squared Solutions Proprietary Limited, Q Squared Solutions Pte. Ltd., Q Squared Solutions S.A., Q2 Solutions, QH Research Limited, QIMS Pharma Services SA DE CV, Qcare Site Services Inc., Quality Health Limited, Quintiles Benin Ltd., Quintiles Clinical and Commercial Nigeria Limited, Quintiles Commercial Laboratorio S.L.U., Quintiles Commercial Rus LLC, Quintiles East Africa Limited, Quintiles Finance Uruguay S.r.L., Quintiles IMS Japan GK, Quintiles Lanka (Private) Limited, Quintiles Mauritius Holdings, Quintiles Medical Development (Shanghai) Co. Ltd., Quintiles Mexico S. de R.L. de C.V., Quintiles New Zealand, Quintiles Phase One Clinical Trials India Private Limited, Quintiles RDS Latin America LLC, Quintiles Site Services S.A., Quintiles West Africa Limited, RX India LLC, Radar Acquisition Blocker Inc., Redsite Limited, Representative Office of IQVIA RDS GesmbH in Moscow, STI Technologies Limited, Schwarzeck Verlag GmbH, Secureconsent LLC, Shanghai IMS Market Research Co. Ltd., Smart I.T. Systems BV, Source Informatics Limited, Spartan Leasing Corporation, StatFin Estonia, Statfinn Oy, Targeted Molecular Diagnostics LLC, Tarius A/S, Temas Srl - Società Unipersonale, TforG Support NV, The Amundsen Group Inc., Themis Limited, UAB IQVIA Commercial, VCG&A Inc., VCG-BIO Inc., Valuecentric Global Services Gmbh, Valuecentric Privacy Solutions LLC, Valuemedics Research LLC, Vivacity Health Pty. Ltd., genae Germany Gmbh, genae International Ag, and iGuard Inc..
Read More
How can I contact IQVIA?

IQVIA's mailing address is 4820 EMPEROR BOULEVARD, DURHAM NC, 27703. The official website for the company is www.iqvia.com. The medical research company can be reached via phone at (919) 998-2000 or via email at ir@iqvia.com.

This page (NYSE:IQV) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -